¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"alpha chain disease"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
À̰ÍÀ» ¿øÇϼ̽À´Ï±î?
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • polycystic kidney disease
    ´Ù³¶½ÅÀ庴, ¹µÁÖ¸Ó´ÏÄáÆÏº´
  • panzootic disease
    µ¿¹°¹üÀ¯Çິ
  • posttransplant lymphoproliferative disease
    À̽ÄÈĸ²ÇÁ¼¼Æ÷Áõ½Äº´
  • prenatal disease
    Ãâ»ýÀüº´
  • primary cholestatic liver disease
    ¿ø¹ß¾µ°³ÁóÁ¤Ã¼°£Áúȯ, ¿ø¹ß´ãÁóÁ¤Ã¼°£Áúȯ
  • primary pigmented nodular adrenocortical disease
    ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½Å°ÑÁúº´, ¿ø¹ß»ö¼ÒÄ§Âø°áÀýºÎ½ÅÇÇÁúº´
  • professional disease
    Àü¹®Á÷¾÷º´, Á÷¾÷º´
  • protozoan disease
    ¿øÃ溴
  • psychosomatic disease
    Á¤½Å½Åüº´
  • pulseless disease
    ¹«¸Æ¹Úº´
  • pyramidal disease
    ÇǶó¹Ìµå½Å°æ·Îº´, Ãßü·Îº´
  • Paget¡¯s disease
    ÆÄÁ¦Æ®º´
  • parasitic disease
    1. ±â»ýÃæº´ 2. ±â»ýÃæÁúȯ
  • Parkinson¡¯s disease
    ÆÄŲ½¼º´
  • paroxysmal disease
    ¹ßÀÛ¼ºÁúȯ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • rheumatoid disease
    ·ù¸¶Æ¼½º¸ð¾çÁúȯ
  • rice disease
    (¢¡beriberi) °¢±â
  • rickettsial disease
    ¸®ÄÉÂ÷º´
  • rolling disease
    ÀüÀüº´
  • runt disease
    ¼Ò¸ðº´, ¿Ö¼Òº´
  • secondary disease
    ¼Ó¹ßº´
  • septic disease
    (¢¡sepsis) ÆÐÇ÷Áõ
  • sexually transmitted disease
    ¼ºº´, ¼º¸Å°³Áúȯ
  • sickle cell disease
    ³´ÀûÇ÷±¸º´, °â»óÀûÇ÷±¸º´
  • sleeping disease
    ¼ö¸éº´
  • slow disease
    Áö¹ßÁúȯ
  • specific disease
    ƯÀÌÁúȯ
  • spinal disease
    ô¼öº´
  • spinocerebellar disease
    ô¼ö¼Ò³úº´
  • spirochetal disease
    ½ºÇÇ·ÎÇ쟺´
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • aphthous fever =foot and mouth disease
    ¾ÆÇÁŸ¼º¿­(¡­æð).
  • apocrine miliaria => Fox Fordyce disease
    ¾ÆÆ÷Å©¸° ÇÑÁø
  • arbovirus disease
    ¾Æ¸£º¸¹ÙÀÌ·¯½ºº´(¡­Ü»)
  • arthropod-borne viral disease
    ÀýÁöµ¿¹° ¸Å°³ ¹ÙÀÌ·¯½ºº´
  • arthropod-borne viral disease
    ÀýÁöµ¿¹°¸Å°³¹ÙÀÌ·¯½º,¾Æº¸¹ÙÀÌ·¯½º
  • functional cardiovascular disease
    ±â´É¼º ½ÉÇ÷°üº´.
  • fungous disease
    Áø±ÕÁúȯ, °õÆÎÀÌÆò
  • gastric vertigo =trousseau disease
    À§(¼º)Çö±â
  • gauchers disease
    °í½¦º´, Gaucher º´
  • generalized obstructive lung disease
    ¹ü¹ß¼º Æó¼â¼º ÆóÁúȯ(ÛñÛ¡àõøÍáð
  • gestational trophoblastic disease
    Àӽżº¿µ¾ç¸ð¼¼Æ÷Áúȯ(¡­ç½å×Ù½á¬øàòðü´)
  • glomerular disease
    »ç±¸Ã¼Áúº´
  • glomerular disease
    »ç±¸Ã¼Áúȯ(ÞêϹô÷òðü´)
  • glucose storage disease
    ´çÃàÀûÁúȯ.
  • glucuronidase deficiency disease
    ±Û·çÅ¥·Î´Ïµ¥À̽º °áÇÌÁõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
  • chronic obstructive pulmonary disease
    ¸¸¼º Æó¼â¼º ÆóÁúȯ
  • cine magulomatous disease
  • climatic disease
    ±âÈĺ´(˻̷ËÓ).
  • cold agglutinin disease
    ÇÑ·©ÀÀÁýÁúȯ(¡­ëêó¢òðü´).
  • cold hemagglutinin disease
    ÇÑ·©(Àû)Ç÷±¸ÀÀÁý¼Ò Áúȯ
  • cold hemagglutinin disease=CHD
    ÇÑ·©Ç÷±¸ÀÀÁý¼Òº´
  • collagen disease
    ±³¿ø(Áú)º´(Îïê«òõÜ»).
  • collagen disease
    ±³¿ø(Áú)º´(Îïê«òõÜ»). ÄݶóÁ¨º´(¡­Ü»)
  • collagen-vascular disease
    ±³¿ø-Ç÷°ü Áúȯ
  • comb disease
    °è°üº´.
  • combined immunodeficiency disease
    º¹ÇÕÇü¸é¿ª°áÇÌÁúȯ
  • combined immunodeficiency disease
    º¹ÇÕÇü ¸é¿ª°áÇÌÁúȯ
  • combined system disease
    º¹ÇÕ°èÅëÁúȯ.
  • combined valvular disease
    º¹ÇÕÆÇ¸·Áúȯ.
  • communicable disease
    Àü¿°º´
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
PCR patient contact record; phosphocreatinine; plasma clearance rate; polymerase chain reaction; post-co...
PDGFA platelet-derived growth factor, A chain
PKCSH protein kinase C heavy chain
PKCSL protein kinase C light chain
RT-PCR reverse transcriptase-polymerase chain reaction
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 20
h-TGF alpha Human transforming growth factor-alpha
HIF-1 alpha Hypoxia inducible factor 1 alpha
IL-2R alpha IL-2 receptor alpha
IKK-alpha IkappaB kinase alpha
IkappaB alpha inhibitory kappa B alpha
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • sporadic disease
    »ê¹ß Áúȯ, »ê¹ß¼º Áúȯ
  • sterility disease
    ºÒÀÓ¼º Áúȯ
  • Still's disease
    ½ºÆ¿ Áúȯ, ½ºÆ¿ º´
    µ¿ÀǾî=juvenile rheumatoid arthritis. 1. Ç÷û¿¡ ÀÌ»óÀÌ ³ªÅ¸³ªÁö ¾Ê´Â °üÀý¿°À¸·Î¼­ Á¾Á¾ ¹ß¿­°ú ¸²ÇÁÀýº´ÁõÀÌ µ¿¹ÝµÇ¸ç 16¼¼ ÀÌÀü¿¡ ½ÃÀÛÇÏ´Â °üÀý¿°ÀÇ 70%¸¦ Â÷ÁöÇÑ´Ù. 2. ¼Ò¾Æ¼º ¸²ÇÁÁ¾ ºñÁ¾¼º À§Ãà ´Ù¹ß¼º °üÀý¿°. ¼Ò¾Æ¿¡ »ý±â´Â ¸¸¼º ´Ù¹ß¼º °üÀý¿°ÀÇ ÀÏÁ¾. ¸²ÇÁÀý Á¾Ã¢, ºñÁ¾, ºÒ±ÔÄ¢¼º ¹ß¿­ÀÌ Æ¯Â¡ÀÌ´Ù.
  • storage pool disease
    ÀúÀåÁ¶º´
    ÀÀÁýÁ¦, ¿¡Çdz×ÇÁ¸°, ¿ÜÀμº ADP, Æ®·Òºó µî¿¡ ¹ÝÀÀÇÏ¿© ADP¸¦ ¹æÃâÇÏ´Â Ç÷¼ÒÆÇ ±â´É ºÎÀü¿¡ ÀÇÇÑ Ç÷¾× ÀÀ°í Àå¾Ö, °¡º­¿î ÃâÇ÷ Áõ»ó, ÃâÇ÷ ½Ã°£ Áö¿¬, ±³¿øÁúÀ̳ª Æ®·Òºó¿¡ ´ëÇÑ ÀÀÁý ¹ÝÀÀÀÇ °¨Å𸦠Ư¡À¸·Î ÇÑ´Ù.
  • stripe disease
    ¼±Á¶º´
  • strumpell's disease Ãø»è °æÈ­ÁõÀÇ À¯ÀüÇüÀ¸·Î ÀÌ Áúº´¿¡¼­ÀÇ °æ·ÃÀº ÁÖ·Î ¹ß¿¡ ÇÑÁ¤µÇ¾î ÀϾ´Ù.

    strychnine

    ½ºÆ®¸®Å©´Ñ
    ±Øµµ·Î µ¶¼ºÀÌ °­ÇÑ ¾ËÄ®·ÎÀ̵å. ÁÖ·Î Strychnos nuxvomica ¹× StrychnosÀÇ ´Ù¸¥ Á¾¿¡¼­ ¾ò¾îÁö¸ç, ½Å°æ Ãæµ¿ÀÇ Á¢ÇպΠÈĺÎÀÇ ¾ïÁ¦¸¦ Â÷´ÜÇÔÀ¸·Î½á ÁßÃß ½Å°æ°èÀÇ ¸ðµç ºÎºÐÀ» ÈïºÐ½ÃŲ´Ù. ÁßÃß ½Å°æ°èÀÇ ÈïºÐÁ¦·Î »ç¿ëµÇ°í ÀÖÀ¸¸ç, ÀÌÀü¿¡´Â °í¹Ì °­ÀåÁ¦, ¼øÈ¯ ÀÚ±ØÁ¦·Î ¶Ç´Â ¼³»çÁ¦¿Í ¾Æ¿ï·¯ »ç¿ëµÇ¾ú´Ù.
  • subacute disease
    ¾Æ±Þ¼º Áúȯ
  • systemic degenerative joint disease
    Àü½Å¼º ÅðÇ༺ °üÀý Áúȯ
  • tay-sachs disease Èæ³»À强 °¡Á·¼º ¹éÄ¡ÀÇ ¿µ¾ÆÇü.

    tazettine

    ŸÁ¦Æ¾
  • temporomandibular joint disease
    ÃøµÎÇϾǰüÀý Áúȯ
  • Thomsen's disease : ¼±Ãµ¼º ±Ù±äÀåÁõ.

    thoracalgia

    È亮Åë
  • thromboembolic disease
    Ç÷Àü »öÀü¼º Áúȯ
  • thyrotoxic heart disease
    °©»ó¼± Áßµ¶¼º ½ÉÀ庴
    °©»ó¼± ±â´É Ç×Áø°ú °ü·ÃÇÑ ½ÉÀå ÁúȯÀ¸·Î ½É¹æ ¼¼µ¿. ½ÉÀå È®´ë, ¿ïÇ÷¼º ½ÉºÎÀü µîÀÌ ³ªÅ¸³­´Ù.
  • tropical disease
    ¿­´ëº´
    °í¿Â ´Ù½ÀÇÏ°í ¹Ì°³¹ß Áö¿ªÀÌ ¸¹Àº ¿­´ë Áö¹æ¿¡¼­ ¸¹ÀÌ ¹ß»ýÇÏ´Â º´. ´ëÇ¥ÀûÀÎ °ÍÀ¸·Î´Â ¾Æ¸Þ¹Ù Àû¸®, Ä®¶ó¾ÆÀÚ¸£
  • tubulo-interstitial disease
    ¼¼´¢°ü-°£Áú¼º Áúȯ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 20
diadenosine 5,5'''-P(1),P(4)-tetraphosphate alpha,beta-phosphorylase <enzyme> Ap4a + inorganic po4 forms ATP + ADP
Registry number: EC 2.7.7.53
Synonym: ap4a phosphorylase, ATP adenylyltransferase
(26 Jun 1999)
dihydrostreptomycin-6-phosphate 3' alpha-kinase <enzyme> Catalyses the phosphorylation of dihydrostreptomycin 6-phosphate in the 3'-position in the presence of ATP
Registry number: EC 2.7.1.88
Synonym: dihydrostreptomycin-6-p 3' alpha-kinase
(26 Jun 1999)
dolichyl-phosphate alpha-N-acetylglucosaminyltransferase <enzyme> Combined with EC 2.4.1.141 forms chitobiosylpyrophosphoryldolichol synthase
Registry number: EC 2.4.1.153
Synonym: dpagtransferase
(26 Jun 1999)
dolichyl-phosphate-mannose-glycolipid alpha-mannosyltransferase <enzyme> Catalyses the transfer of mannose from dolichyl-p-mannose to the man(5)(glcnac)2-pp-dolichol acceptor glycolipid
Registry number: EC 2.4.1.130
Synonym: dolichyl-p-mannose-dolichyl-pp-heptasaccharide alpha-mannosyltransferase, dolichyl-p-mannose-man(5)(glcnac)2-pp-dolichol mannosyltransferase, dpm-g-mannosyltransferase
(26 Jun 1999)
D-selenocystine alpha, beta-lyase <enzyme> From clostridium sticklandii; pyridoxal-p enzyme; mw 74kda; decomposes d-selenocystine into pyruvate, nh3 and elemental selenium; d-cystine, d-lanthionine, meso-lanthionine and d-cysteine can also serve as substrates; d-selenocysteine, d-serine, dl-selenohomocystine and l-amino acids are inert
Registry number: EC 4.99.-
Synonym: dsc-ab-lyase
(26 Jun 1999)
I kappa B alpha-associated protein kinase <enzyme> Isolated from human monocytic cell line; phosphorylates ser(293), ser(288), and thr(291) of ikappabalpha
Registry number: EC 2.7.10.-
Synonym: ikappabalpha-associated protein kinase, ikappab-alpha-associated protein kinase, ikappabalpha kinase
(26 Jun 1999)
indolyl-3-alkane-alpha-hydroxylase <enzyme> Indoyl-3-alkane-alpha-hydroxylase; haemprotein which needs no cofactor
Registry number: EC 1.13.99.-
Synonym: tryptophan side chain oxidase
(26 Jun 1999)
inositol 1-alpha-galactosyltransferase <enzyme> Catalyses conversion of udpgalactose plus myo-inositol to galactinol plus udp
Registry number: EC 2.4.1.123
Synonym: galactinol synthase
(26 Jun 1999)
inter-alpha-inhibitor <chemical> Inhibits bovine trypsin and chymotrypsin; complex formed with chymotrypsin less stable; alpha-glycoprotein; shap - serum-derived hyaluronan associated protein
Pharmacological action: serine proteinase inhibitors, trypsin inhibitors
Chemical name: trypsin inhibitor, inter-alpha-
Synonym: inter-alpha-trypsin inhibitor, protein pi, inter-alpha-trypsin inhibitor, heavy chain, shap protein
(05 Dec 1998)
interferon-alpha <cytokine> One of the type I interferons produced by peripheral blood leukocytes or lymphoblastoid cells when exposed to live or inactivated virus, double-stranded RNA, or bacterial products.
It is the major interferon produced by virus-induced leukocyte cultures and, in addition to its pronounced antiviral activity, causes activation of NK cells. It is used experimentally in the treatment of hairy-cell leukaemia.
A number of different subtypes exist that are elaborated by leukocytes in response to viral infection or stimulation with double-stranded RNA; IFN-alpha-2A and -2B are protein products made by recombinant DNA techniques and are used as antineoplastic agents.
See: interferon-alpha 2a, interferon-alpha 2b
Synonym: leukocyte interferon.
Pharmacological action: antineoplastic agent, antiviral agent.
(20 Sep 2002)
interferon-alpha 2a <cytokine> Interferon a (human leukocyte protein moiety reduced). A type I interferon consisting of 165 amino acid residues with lysine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.
Pharmacological action: antineoplastic agent, antiviral agents.
Chemical name: Interferon-alphaA (human leukocyte protein moiety reduced)
(12 Dec 1998)
interferon-alpha 2b <chemical> Interferon alpha 2b (human leukocyte clone hif-sn 206 protein moiety reduced). A type I interferon consisting of 165 amino acid residues with arginine in position 23. This protein is produced by recombinant DNA technology and resembles interferon secreted by leukocytes. It is used extensively as an antiviral or antineoplastic agent.
Pharmacological action: antineoplastic agent, antiviral agents.
(12 Dec 1998)
testosterone 15-alpha hydroxylase <enzyme> A haem-thiolate protein (cytochrome p-450)
Registry number: EC 1.14.15.-
Synonym: cytochrome p-450(15alpha), testosterone 15-alpha monooxygenase, steroid 15-alpha-hydroxylase, cytochrome p-4502a-4, cyp2a-4, cyp2a4
(26 Jun 1999)
testosterone 5-alpha-reductase <enzyme> Chemical name: 3-Oxo-5 alpha-steroid:(acceptor) delta(4)-oxidoreductase
Registry number: EC 1.3.99.5
(12 Dec 1998)
TM-1 alpha-fibrinogenase <enzyme> Isolated from the venom of taiwan habu, trimeresurus mucrosqamatus
Registry number: EC 3.4.24.-
(26 Jun 1999)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 20
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 20
ÅëÇÕ°Ë»ö ¿Ï·á